logo-loader
RNS
viewAmphion Innovations PLC

AIM - Cancellation - Amphion Innovations plc

RNS Number : 4159Y
AIM
02 January 2020
 

NOTICE

 

02/01/2020 7:00am

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

 

Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 

AMPHION INNOVATIONS PLC

213800M7MTE2W2P6C104

 

ORDINARY SHARES OF 1P EACH, FULLY PAID

(B0DJNP9)(GB00B0DJNP99)

AMPN INNO/PAR VTG FPD 0.01

 

If you have any queries or require further information, please contact the company's nominated adviser on +44 (0)20 7886 2500


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AMOUARARKRAUOAA

Quick facts: Amphion Innovations PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success

Richard Morgan, chief executive of Amphion PLC (LON:AMP), discusses the 'very welcome' Phase III Iclaprim news from Motif Bio. Motif's recently revealed its lead drug, a next generation antibiotic, successfully negotiated a crucial final-stage clinical study, boosting Amphion’s...

on 10/10/17